Luminor Medical Technologies Inc. completed the acquisition of RISE Research Inc. and plans to change its name to RISE Life Science Corp. at its annual general meeting Feb. 27.
RISE Research is a privately held developer of cannabis consumer products both for medical- and adult-use consumer market sectors.
Luminor Medical appointed Chris Dollard, co-founder of RISE Research, as a director and COO of the combined entity.
Constance Finley, CEO of cannabis company Constance Therapeutics, was also nominated to the board. Finley plans to officially join the board upon ratification at the company's annual general meeting.
RISE Research's CEO Anton Mattadeen has become Luminor Medical's CEO as per the terms of the acquisition.
To accommodate the appointments, Luminor Medical's pre-acquisition CEO Christian Sauvageau resigned from his former board and officer positions.
